Trending...
- Plaza Mexico presents "Good Friday Celebration"
- California: Governor Newsom announces appointments 3.20.2026
- California announces 300 wildfire projects fast-tracked in 300 days
IRVINE, Calif.--(BUSINESS WIRE)--Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi® has received CE Mark certification. This allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.
Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology, Clarifi is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care. Clarifi's fully-integrated solution is rapidly gaining acceptance by clinicians across the continuum of care for assessing potential circulatory compromise to manage and treat diabetic, venous and pressure ulcers, acute and chronic wounds, burns, and amputations.
More on The Californer
"Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim," said David Cuccia, Ph.D., Modulim's President and CTO. "This achievement allows us to expand our addressable market and deliver a complete microvascular assessment solution that helps clinicians prevent lower limb complications in patients with diabetes as well as other life-altering circulatory issues. We are now able to bring our innovative technology to our European clinical partners, and grow our ever expanding image library by reaching the 60 million diabetes patients in the EU."
Clarifi can help clinicians identify potential compromised circulation and pre-ulcerative conditions, before they are visible, so they can implement timely and targeted intervention to prevent costly and deadly complications. Powered by SFDI, Clarifi provides new information that enables healthcare providers in all environments to transition from reactive care to proactive care.
More on The Californer
The Clarifi Imaging System demonstrates Modulim's continuing mission to deliver transformative optical solutions that help people live healthier, longer lives.
About Modulim
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology, Clarifi is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care. Clarifi's fully-integrated solution is rapidly gaining acceptance by clinicians across the continuum of care for assessing potential circulatory compromise to manage and treat diabetic, venous and pressure ulcers, acute and chronic wounds, burns, and amputations.
More on The Californer
- The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
- California: Governor Newsom terminates states of emergency – 3.24.26
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- TCVN & CloneForce bring Agentic AI Pitch to Survivor 13 at Octane's OC Innovation Week at UCI
- Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
"Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim," said David Cuccia, Ph.D., Modulim's President and CTO. "This achievement allows us to expand our addressable market and deliver a complete microvascular assessment solution that helps clinicians prevent lower limb complications in patients with diabetes as well as other life-altering circulatory issues. We are now able to bring our innovative technology to our European clinical partners, and grow our ever expanding image library by reaching the 60 million diabetes patients in the EU."
Clarifi can help clinicians identify potential compromised circulation and pre-ulcerative conditions, before they are visible, so they can implement timely and targeted intervention to prevent costly and deadly complications. Powered by SFDI, Clarifi provides new information that enables healthcare providers in all environments to transition from reactive care to proactive care.
More on The Californer
- New Book Reveals The Science Of Predictions
- Governor Newsom calls FCC Chair Brendan Carr a "disgrace," says California will lead more antitrust enforcement to protect consumers from Trump's rising costs
- California doubles down on ocean health with historic investments, following landmark report findings
- New Dosio App Helps GLP-1 Users Track Shots, Side Effects, and Weight Trends
- Rachel Farris, CPA and Founder of Tax Stack AI, Featured on The Big 4 Transparency Podcast
The Clarifi Imaging System demonstrates Modulim's continuing mission to deliver transformative optical solutions that help people live healthier, longer lives.
About Modulim
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
Filed Under: Business
0 Comments
Latest on The Californer
- SoCal Locksmith With 113K YouTube Subscribers Shares Car Theft Prevention Tips
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- 438–444 N. La Cienega Boulevard Trades in West Hollywood's Premier Design Corridor
- California Housing Crisis Sparks Growth: Dave Simmons and StrataX Development Double Down on ADU Expansion
- California and European Commission discuss cooperation to accelerate the global transition to a carbon-neutral, resilient, and equitable future
- California Lutheran University Expands Board of Regents
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- California: Governor Newsom announces appointments 3.23.2026
- Breaking the Civilian Barrier: ResuModAI Helps Veterans Translate Military Service into Job Offers in 60 Seconds
- Global Leaders Meet in Baku: The World Is Running Out of Time
- Long Beach Parks, Recreation and Marine to Offer Youth Summer Day Camps
- USFITC Extends International Defense Supply Capabilities with Sealing Component Delivery
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- For Financial Literacy Month: Check out "TINA, TARA, TAPAS & TIARA" & "Better Than Expected Losses"
- Benchmark International Successfully Facilitated the Transaction Between LPAS, Inc. and Bluwatr
- TIME WASTED: The 2027 Releasing TV Show
- JetPipe Plumbing Brings Licensed, Specialized Plumbing Services to the San Francisco Bay Area
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- A-One Janitorial Wins $152M AI Campus Contract — Meta, Microsoft, Google, and AWS